Skip to content

Clinical trials

Phase 4 Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 4 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20111
20152
20161
20171
20181
20191
20201
20222
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Qilu Hospital of Shandong University2
University of Sao Paulo General Hospital2
Actelion1
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1
Brigham and Women's Hospital1
Coordinación de Investigación en Salud, Mexico1
Duke University1
Federal University of São Paulo1
Johns Hopkins University1
Peking University Third Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic18
Arthritis, Rheumatoid5
Connective Tissue Diseases5
Myositis4
Arthritis, Juvenile3
Lupus Erythematosus, Systemic3
Antiphospholipid Syndrome2
Dermatomyositis2
Hypertension, Pulmonary2
Lung Diseases, Interstitial2

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.